You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

germline BRCA

Showing 1 - 25 of 550
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

Not yet recruiting
  • BRCA Mutation
  • +2 more
  • Germinal BRCA
  • (no location specified)
Mar 3, 2023

Germline BRCA-mutated HER2-negative Breast Cancer Trial in Beijing (Camrelizumab+Fluzoparib)

Enrolling by invitation
  • Germline BRCA-mutated HER2-negative Breast Cancer
  • Beijing, Beijing, China
    Breast Cancer, Peking University People's Hospital
Nov 14, 2022

TNBC - Triple-Negative Breast Cancer Trial in Nanjing (Fluzoparib+Paclitaxel, Epirubicin+Cyclophosphamide)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Nanjing, Jiangsu, China
    JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Apr 27, 2023

Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • +7 more
  • (no location specified)
Aug 1, 2022

Breast & Ovarian Cancer Risk Detection

Recruiting
  • Adnexal Mass
  • +3 more
  • OVA360
  • Austin, Texas
    Silvana Franco
Jul 20, 2022

Breast Cancer After Ovarian Cancer During and/or After Therapy:

Recruiting
  • BRCA-Associated Breast Carcinoma
  • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 9, 2023

Breast Cancer Metastatic Trial in Beijing (TSL-1502 capsules(low dose), TSL-1502 capsules(high dose), Investigator's choice of

Not yet recruiting
  • Breast Cancer Metastatic
  • TSL-1502 capsules(low dose)
  • +2 more
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Jun 13, 2022

Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

Recruiting
  • Stage I Breast Cancer
  • +7 more
  • Baltimore, Maryland
  • +6 more
Nov 11, 2022

Molecular Profiling in Prostate Cancer

Recruiting
  • Prostate Cancer Metastatic
  • +4 more
  • Tumor molecular profiling
  • Athens, Greece
    Hellenic Cooperative Oncology Group
Mar 15, 2022

Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by

Completed
  • Breast Cancer
  • Blood test
  • Questionnaire
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 27, 2021

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 31, 2022

Germline Variant Carriers With BRCA1 or BRCA2

Recruiting
  • BRCA1 and/or BRCA2 Variant Carriers
  • +3 more
    • Okayama, Japan
      Okayama University
    Dec 25, 2022

    Among Talazoparib-Treated HER2-Negative mBC With gBRCA1/2m

    Completed
    • Metastatic Breast Cancer
    • Breast Neoplasms
    • New York, New York
      Pfizer Inc.
    Aug 5, 2022

    Clinical Significance of Germline BRCA Mutations

    Recruiting
    • Breast Cancer
    • Ovarian Cancer
      • Basking Ridge, New Jersey
      • +6 more
      Oct 6, 2021

      Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or

      Recruiting
      • Ovarian Cancer
        • Seoul, Korea, Republic of
          Yonsei University Health System, Severance Hospital
        Jul 13, 2022

        Searching for Novel Germline Mutations in Lobular Breast Cancer

        Recruiting
        • Lobular Breast Carcinoma
        • +3 more
        • Illumina panel
        • Milan, Italy
          European Institute of Oncology
        Sep 12, 2022

        Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

        Not yet recruiting
        • Prostate Adenocarcinoma
        • +2 more
        • Biospecimen Collection
        • +6 more
        • (no location specified)
        Mar 28, 2023

        Breast Cancer, Breast Cancer Metastatic Trial in Spain (Niraparib 100 MG, Aromatase Inhibitors)

        Terminated
        • Breast Cancer
        • Breast Cancer Metastatic
        • Niraparib 100 MG
        • Aromatase Inhibitors
        • A Coruña, Spain
        • +9 more
        Jan 17, 2023

        Ovarian Cancer, Breast Cancer Trial in India (Olaparib)

        Completed
        • Ovarian Cancer
        • Breast Cancer
        • Ahmedabad, India
        • +15 more
        Oct 28, 2022

        Germline Mutations Associated With Hereditary Pancreatic Cancer

        Recruiting
        • Pancreatic Cancer
        • Pancreatic Adenocarcinoma
        • Invitae Multi-Cancer Panel ®
        • Mexico City, Mexico
          Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
        Mar 22, 2022

        US Talazoparib-Treated Locally Advanced or Metastatic Breast

        Completed
        • Breast Cancer
        • New York, New York
          Pfizer Inc
        Nov 22, 2021

        Prostate Cancer Screening in Men With Germline BRCA2 Mutations

        Completed
        Has Results
        • Prostate Cancer
          • New Haven, Connecticut
            Yale University
          Jan 21, 2021

          MAstectomy With Reconstruction Including Robot Endoscopic

          Recruiting
          • Breast Neoplasms
          • +4 more
          • Robotic or endoscopic nipple sparing mastectomy
          • Conventional mastectomy (including nipple sparing mastectomy, skin sparing mastectomy)
          • Seoul, Korea, Republic of
            Yonsei University College of Medicine
          Jun 4, 2021

          Breast Cancer Trial in France (Main study:, Sub-study:)

          Recruiting
          • Breast Cancer
          • Main study:
          • Sub-study:
          • Bordeaux, France
          • +20 more
          Jan 2, 2023

          BRCA1 Mutation, Breast Cancer, Breast Diseases Trial in United States (Denosumab, Placebo, Quality-of-Life Assessment)

          Not yet recruiting
          • BRCA1 Mutation
          • +5 more
          • (no location specified)
          Jul 19, 2021